+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Respiratory Infection Diagnostics Market by Test (Antigen Detection Assays, Direct Fluorescent Antibody Tests, Imaging Tests), Disease (Asthma, Chronic Obstructive Pulmonary Disease, Coronavirus Infections), End-User - Forecast 2024-2030- Product Image
Global Respiratory Infection Diagnostics Market by Test (Antigen Detection Assays, Direct Fluorescent Antibody Tests, Imaging Tests), Disease (Asthma, Chronic Obstructive Pulmonary Disease, Coronavirus Infections), End-User - Forecast 2024-2030- Product Image
Sale

Global Respiratory Infection Diagnostics Market by Test (Antigen Detection Assays, Direct Fluorescent Antibody Tests, Imaging Tests), Disease (Asthma, Chronic Obstructive Pulmonary Disease, Coronavirus Infections), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5675119
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Respiratory Infection Diagnostics Market size was estimated at USD 76.94 billion in 2023, USD 82.35 billion in 2024, and is expected to grow at a CAGR of 7.15% to reach USD 124.78 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Respiratory Infection Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Respiratory Infection Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Infection Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co. Ltd., Atomo Diagnostics Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., bioMerieux SA, BIORON Diagnostics GmbH, Cardinal Health Inc., Chembio Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, Meridian Bioscience Inc. by SD Biosensor, Quest Diagnostics Incorporated, and Quidel Corporation.

Market Segmentation & Coverage

This research report categorizes the Respiratory Infection Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test
    • Antigen Detection Assays
    • Direct Fluorescent Antibody Tests
    • Imaging Tests
      • CT- Scan
      • X-ray
    • In Vitro Diagnostics (IVD) Tests
    • Nucleic Acid Amplification Tests
    • Rapid Diagnostic Tests
  • Disease
    • Asthma
    • Chronic Obstructive Pulmonary Disease
    • Coronavirus Infections
    • Enterovirus
    • Influenza diseases
    • Lung Cancer
    • Pneumonia
    • Tuberculosis
    • Whooping Cough (Pertussis)
  • End-User
    • Clinical Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Respiratory Infection Diagnostics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Respiratory Infection Diagnostics Market?
  3. What are the technology trends and regulatory frameworks in the Respiratory Infection Diagnostics Market?
  4. What is the market share of the leading vendors in the Respiratory Infection Diagnostics Market?
  5. Which modes and strategic moves are suitable for entering the Respiratory Infection Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Respiratory Infection Diagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of chronic obstructive pulmonary disease (COPD)
5.1.1.2. Increasing healthcare infrastructure coupled with the availability of diagnostic procedures
5.1.1.3. Rapid rise in government funding towards infectious disease diagnostics
5.1.2. Restraints
5.1.2.1. High cost of diagnosis and testing limited reimbursement scenarios
5.1.3. Opportunities
5.1.3.1. Availability of next-generation sequencing-based platform to diagnose respiratory tract infections
5.1.3.2. Expanding number of R&D activities
5.1.4. Challenges
5.1.4.1. Strict regulatory constraints
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Respiratory Infection Diagnostics Market, by Test
6.1. Introduction
6.2. Antigen Detection Assays
6.3. Direct Fluorescent Antibody Tests
6.4. Imaging Tests
6.5.1. CT- Scan
6.5.2. X-ray
6.5. In Vitro Diagnostics (IVD) Tests
6.6. Nucleic Acid Amplification Tests
6.7. Rapid Diagnostic Tests
7. Respiratory Infection Diagnostics Market, by Disease
7.1. Introduction
7.2. Asthma
7.3. Chronic Obstructive Pulmonary Disease
7.4. Coronavirus Infections
7.5. Enterovirus
7.6. Influenza diseases
7.7. Lung Cancer
7.8. Pneumonia
7.9. Tuberculosis
7.10. Whooping Cough (Pertussis)
8. Respiratory Infection Diagnostics Market, by End-User
8.1. Introduction
8.2. Clinical Laboratories
8.3. Hospitals
9. Americas Respiratory Infection Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Respiratory Infection Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Respiratory Infection Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. AccuBioTech Co. Ltd.
13.1.3. Atomo Diagnostics Ltd.
13.1.4. Becton, Dickinson and Company
13.1.5. Bio-Rad Laboratories Inc.
13.1.6. bioMerieux SA
13.1.7. BIORON Diagnostics GmbH
13.1.8. Cardinal Health Inc.
13.1.9. Chembio Diagnostics, Inc.
13.1.10. F. Hoffmann-La Roche Ltd.
13.1.11. Hologic, Inc.
13.1.12. Merck KGaA
13.1.13. Meridian Bioscience Inc. by SD Biosensor
13.1.14. Quest Diagnostics Incorporated
13.1.15. Quidel Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. RESPIRATORY INFECTION DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RESPIRATORY INFECTION DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
FIGURE 8. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 10. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. RESPIRATORY INFECTION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. RESPIRATORY INFECTION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. RESPIRATORY INFECTION DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 6. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ANTIGEN DETECTION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DIRECT FLUORESCENT ANTIBODY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 10. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CT- SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD) TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 16. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CORONAVIRUS INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ENTEROVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFLUENZA DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY WHOOPING COUGH (PERTUSSIS), BY REGION, 2018-2030 (USD MILLION)
TABLE 25. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 42. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 43. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 44. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 46. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 64. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 65. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 66. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. INDIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 68. INDIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 69. INDIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 70. INDIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. JAPAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 76. JAPAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 77. JAPAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 78. JAPAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. THAILAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 100. THAILAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 101. THAILAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 102. THAILAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 113. DENMARK RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 114. DENMARK RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 115. DENMARK RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. EGYPT RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 117. EGYPT RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 118. EGYPT RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FINLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 121. FINLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 122. FINLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 125. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 126. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 129. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 137. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 138. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 139. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. NORWAY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 149. NORWAY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 150. NORWAY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. POLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 153. POLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 154. POLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 155. POLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. QATAR RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 157. QATAR RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 158. QATAR RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 159. QATAR RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SPAIN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 173. SPAIN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 174. SPAIN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. TURKEY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 185. TURKEY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 186. TURKEY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 187. TURKEY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. RESPIRATORY INFECTION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 197. RESPIRATORY INFECTION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 198. RESPIRATORY INFECTION DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AccuBioTech Co. Ltd.
  • Atomo Diagnostics Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • BIORON Diagnostics GmbH
  • Cardinal Health Inc.
  • Chembio Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Merck KGaA
  • Meridian Bioscience Inc. by SD Biosensor
  • Quest Diagnostics Incorporated
  • Quidel Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 82.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 124.78 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Respiratory Diagnostics Market by Product (Assays & Reagents, Instruments & Devices, Software & Services), Test Type (Imaging Tests, Mechanical Tests, Molecular Diagnostic Tests), Indication, End-User - Forecast 2023-2030 - Product Image

Global Respiratory Diagnostics Market by Product (Assays & Reagents, Instruments & Devices, Software & Services), Test Type (Imaging Tests, Mechanical Tests, Molecular Diagnostic Tests), Indication, End-User - Forecast 2023-2030

  • Report
  • 192 Pages
  • Global
From
Global Respiratory Disease Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Respiratory Disease Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Executive and Consultant Guides 2024-2028 - Product Image

Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Executive and Consultant Guides 2024-2028

  • Report
  • 602 Pages
  • Global
From
Global Respiratory Disease Testing Market by Product (Blood Gas Test, Imaging Tests, Respiratory Measurement), End-Use (Clinical Laboratories, Hospitals, Physician Clinics) - Forecast 2024-2030 - Product Image

Global Respiratory Disease Testing Market by Product (Blood Gas Test, Imaging Tests, Respiratory Measurement), End-Use (Clinical Laboratories, Hospitals, Physician Clinics) - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 174 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.